Avastin + Tarceva = better results in lung cancer - Genentech said the trial was stopped early after an interim analysis found that combining Avastin, known generically as bevacizumab, and Tarceva, or …
Pharma News 10_03
Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma Web Branding, Part 8 – BMS
It had been a long time since I'd gone on Bristol-Myers' site. So it was a pleasant surprise when, a few moments after typing www.bms.com into my browser, an interesting voice began speaking to …